Lymphadenectomy Improves Survival of Patients With Renal Cell Carcinoma and Nodal Metastases
Abstract
Purpose:
In a population based cohort we determined whether an increase in the number of lymph nodes removed is associated with improved disease specific survival of patients with renal cell carcinoma treated with nephrectomy.
Materials and Methods:
Patients in the Surveillance, Epidemiology and End Results database with renal cell carcinoma and no evidence of distant metastases were identified. Those patients included in the study underwent radical or partial nephrectomy with lymphadenectomy. Cox regression analyses were performed to identify factors associated with disease specific survival including an interaction between lymph node status and the number of lymph nodes removed.
Results:
Between 1988 and 2006, 9,586 patients with renal cell carcinoma met the study inclusion criteria. Median followup was 3.5 years (range 1.4 to 6.8). Of the patients 2,382 (25%) died of renal cell carcinoma, including 1,646 (20%) with lymph node negative disease and 736 (58%) with lymph node positive disease. There was no effect on disease specific survival with increasing the extent of lymphadenectomy in patients with negative lymph nodes (HR 1.0, 95% CI 0.9–1.1, p = 0.93). However, patients with positive lymph nodes had increased disease specific survival with extent of lymphadenectomy (HR 0.8 per 10 lymph nodes removed, 95% CI 0.7–1.0, p = 0.04). An increase of 10 lymph nodes in a patient with 1 positive lymph node was associated with a 10% absolute increase in disease specific survival at 5 years (p = 0.004).
Conclusions:
This study shows an association between increased lymph node yield and improved disease specific survival of patients with lymph node positive nonmetastatic renal cell carcinoma who underwent lymphadenectomy. Patients at high risk for nodal disease should be considered for regional or extended lymphadenectomy. Clinical variables to predict risk and validation of dissection templates are important areas for future research.
References
- 1 : Cancer Statistics, 2010. CA Cancer J Clin2010; 60: 277. Google Scholar
- 2 : Tumor size improves the accuracy of TNM predictions in patients with renal cancer. Eur Urol2006; 50: 521. Google Scholar
- 3 : Prognostic significance of lymph node invasion in patients with metastatic renal cell carcinoma: a population-based perspective. Cancer2009; 115: 5680. Google Scholar
- 4 : A protocol for performing extended lymph node dissection using primary tumor pathological features for patients treated with radical nephrectomy for clear cell renal cell carcinoma. J Urol2004; 172: 465. Link, Google Scholar
- 5 : Radical extensive surgery for renal cell carcinoma: long-term results and prognostic factors. J Urol1990; 143: 468. Link, Google Scholar
- 6 : Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease (clinical stage TxN1-2M0): the impact of aggressive surgical resection on patient outcome. J Urol2006; 175: 864. Link, Google Scholar
- 7 : Stage-specific effect of nodal metastases on survival in patients with non-metastatic renal cell carcinoma. BJU Int2009; 103: 33. Google Scholar
- 8 : Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection. J Urol2003; 169: 2076. Link, Google Scholar
- 9 : Radical nephrectomy with and without lymph-node dissection: final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881. Eur Urol2009; 55: 28. Google Scholar
- 10 : TNM Classification of Malignant Tumours. New York: Wiley-Liss2002. pp xxiii, 239. Google Scholar
- 11 : Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis. Lancet2003; 361: 1927. Google Scholar
- 12 : Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial. J Urol2009; 181: 956. Link, Google Scholar
- 13 : Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol2002; 167: 1295. Link, Google Scholar
- 14 : Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results Program data base. J Urol2003; 169: 946. Link, Google Scholar
- 15 : Flow-cytometric determination of tumor cells in lymph nodes. Oncology2002; 62: 128. Google Scholar
- 16 : The number of lymph nodes examined and staging accuracy in renal cell carcinoma. BJU Int2003; 91: 37. Google Scholar
- 17 : The Will Rogers phenomenon: Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer . N Engl J Med1985; 312: 1604. Google Scholar
- 18 : TNM Classification of Malignant Tumours. New York: J. Wiley1997. pp xxiii, 227. Google Scholar
- 19 : The role of lymphadenectomy in renal cell carcinoma. Curr Opin Urol2009; 19: 465. Google Scholar
- 20 : Value of frozen section analysis of enlarged lymph nodes during radical nephrectomy for renal cell carcinoma. Urology2009; 74: 364. Google Scholar
- 21 : Impact of lymphadenectomy and nodal burden in renal cell carcinoma: retrospective analysis of the National Surveillance, Epidemiology, and End Results database. Urology2005; 65: 675. Google Scholar
- 22 : Laparoscopic radical nephrectomy for patients with T2 and T3 renal-cell carcinoma: evaluation of perioperative outcomes. J Endourol2009; 23: 1527. Google Scholar
- 23 : Laparoscopic radical nephrectomy with hilar lymph node dissection in patients with advanced renal cell carcinoma. Urology2007; 70: 43. Google Scholar
- 24 : Laparoscopic lymph node dissection in clinically node-negative patients undergoing laparoscopic nephrectomy for renal carcinoma. Urology2008; 71: 287. Google Scholar
